Published in World J Gastroenterol on January 28, 2008
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res (2009) 1.80
Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol (2014) 1.26
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology (2015) 1.24
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol Cancer (2011) 1.22
Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci (2015) 1.09
Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br J Cancer (2009) 1.08
Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocr Relat Cancer (2011) 1.03
Advances in epigenetic biomarker research in colorectal cancer. World J Gastroenterol (2014) 1.02
Early detection of colorectal cancer: from conventional methods to novel biomarkers. J Cancer Res Clin Oncol (2015) 0.92
Diagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysis. Can J Gastroenterol (2013) 0.89
Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer. World J Gastroenterol (2010) 0.87
DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. BMC Cancer (2015) 0.83
Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives. World J Gastrointest Oncol (2015) 0.82
Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis. World J Gastroenterol (2014) 0.82
Fecal molecular markers for colorectal cancer screening. Gastroenterol Res Pract (2011) 0.82
Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data. Oncol Rep (2015) 0.81
Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection. Front Genet (2014) 0.80
Methylation-mediated loss of SFRP2 enhances melanoma cell invasion via Wnt signaling. Am J Transl Res (2016) 0.80
Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening. J Natl Compr Canc Netw (2016) 0.79
Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection. Int J Colorectal Dis (2012) 0.78
Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma. World J Gastroenterol (2012) 0.76
Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening. Yonsei Med J (2009) 0.76
A pan-cancer analysis of secreted Frizzled-related proteins: re-examining their proposed tumour suppressive function. Sci Rep (2017) 0.75
Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model. Genet Mol Biol (2013) 0.75
DNA methylation assay for colorectal carcinoma. Cancer Biol Med (2017) 0.75
Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer. Int J Mol Sci (2017) 0.75
p33(ING1b) methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. Oncol Lett (2014) 0.75
The Diagnostic Performance of Stool DNA Testing for Colorectal Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.75
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol (2007) 11.04
MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res (2000) 9.30
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res (2005) 6.49
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet (2002) 5.38
Colorectal cancer. Lancet (2005) 4.90
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68
APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer (2001) 4.54
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst (2005) 3.73
Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70
A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A (1997) 2.70
Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol (2006) 1.99
Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet (2004) 1.80
Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer (2005) 1.75
Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res (2005) 1.59
Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol (2002) 1.56
Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol (2004) 1.50
Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol (2006) 1.45
CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer (2006) 1.44
Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol (2005) 1.27
A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol Biol (2003) 1.26
Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med (2004) 1.21
Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci (2007) 1.19
Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol (2007) 1.19
DNA methylation in colorectal cancer--impact on screening and therapy monitoring modalities? Dis Markers (2007) 1.17
CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol (2005) 1.15
DNA methylation analysis by MethyLight technology. Methods (2001) 1.15
Promoter methylation precedes chromosomal alterations in colorectal cancer development. Cell Oncol (2006) 1.03
Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas. Int J Cancer (2007) 0.93
DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients. Int J Cancer (2006) 0.92
Colorectal cancer screening. World J Gastroenterol (2006) 0.88
Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible? J Natl Cancer Inst (2005) 0.88
CT colonography: results and limitations. Eur J Radiol (2006) 0.85
Flat adenomas. ANZ J Surg (2007) 0.84
[SFRP, a family of new colorectal tumor suppressor candidate genes]. Nihon Rinsho (2005) 0.84
Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up. Dig Dis (2007) 0.81
Prevention and early detection of colorectal cancer--new horizons. Recent Results Cancer Res (2007) 0.79
[Emerging concepts in colorectal serrated polyps]. Gastroenterol Clin Biol (2007) 0.79
Detection of fecal DNA methylation for colorectal neoplasia: does it lead to an optimal screening test? Acta Med Okayama (2006) 0.78
New gene discoveries may boost DNA stool testing for colorectal cancer. J Natl Cancer Inst (2004) 0.77
[Fecal methylated DNA for the detection of colorectal cancer]. Z Gastroenterol (2006) 0.77
The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis. PLoS One (2013) 1.03
Propofol combined with traditional sedative agents versus propofol- alone sedation for gastrointestinal endoscopy: a meta-analysis. Scand J Gastroenterol (2012) 1.01
Impact of postoperative complications on long-term survival after radical resection for gastric cancer. World J Gastroenterol (2013) 0.99
Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer. Oncol Rep (2012) 0.98
Comparison between single-incision and conventional three-port laparoscopic appendectomy: a meta-analysis from eight RCTs. Int J Colorectal Dis (2013) 0.95
Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways. Acta Pharmacol Sin (2012) 0.94
Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer. Oncol Rep (2011) 0.90
Comparison between totally laparoscopic and laparoscopically assisted distal gastrectomy for gastric cancer with a short follow-up: a meta-analysis. J Laparoendosc Adv Surg Tech A (2013) 0.87
CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis. World J Gastroenterol (2006) 0.83
High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients. Tumour Biol (2013) 0.83
Transforming growth factor β-induced epithelial-mesenchymal transition increases cancer stem-like cells in the PANC-1 cell line. Oncol Lett (2011) 0.83
Neuron-glial communication mediated by TNF-α and glial activation in dorsal root ganglia in visceral inflammatory hypersensitivity. Am J Physiol Gastrointest Liver Physiol (2014) 0.81
Role of voltage gated Ca2+ channels in rat visceral hypersensitivity change induced by 2,4,6-trinitrobenzene sulfonic acid. Mol Pain (2013) 0.81
MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2. Cancer Lett (2012) 0.80
Totally laparoscopic vs. laparoscopically assisted distal gastrectomy for gastric cancer: a meta-analysis. Hepatogastroenterology (2013) 0.80
Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer. Med Hypotheses (2013) 0.79
[Design of Non-Invasive Blood Oxygen Measurement Based on AFE4490]. Zhongguo Yi Liao Qi Xie Za Zhi (2015) 0.75
Ultra-high resolution nano-characterisation and analysis using advanced S/TEM. J Nanosci Nanotechnol (2009) 0.75
Two kinds of ENU-induced scant hair mice and mapping of the mutant genes. J Dermatol Sci (2004) 0.75
Palladium-catalyzed oxidative carbonylation of hydrazides: synthesis of 1,3,4-oxadiazol-2(3H)-ones. Chem Commun (Camb) (2015) 0.75
Common Visual Pattern Discovery via Nonlinear Mean Shift Clustering. IEEE Trans Image Process (2015) 0.75
[Investigation and canonical correspondence analysis of salinity contents in secondary salinization greenhouse soils in Shanghai suburb]. Huan Jing Ke Xue (2014) 0.75
GaAs:Mn nanowires grown by molecular beam epitaxy of (Ga,Mn)as at MnAs segregation conditions. Nano Lett (2007) 0.75